BX Swiss - USA
0,00
PKT
±0,00
PKT
±0,00
%
Werbung
Analysen zu BX Swiss - USA-Werten
Datum | Rating | Analyst | |
---|---|---|---|
13.03.24 | JPMorgan Chase Outperform | RBC Capital Markets | |
13.03.24 | Boeing Buy | Goldman Sachs Group Inc. | |
12.03.24 | Apple Buy | Jefferies & Company Inc. | |
12.03.24 | Boeing Buy | UBS AG | |
12.03.24 | Boeing Outperform | RBC Capital Markets | |
12.03.24 | Oracle Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
12.03.24 | FedEx Buy | Goldman Sachs Group Inc. | |
12.03.24 | Oracle Neutral | Goldman Sachs Group Inc. | |
12.03.24 | Nike Buy | UBS AG | |
12.03.24 | Oracle Overweight | Barclays Capital | |
12.03.24 | Oracle Buy | UBS AG | |
12.03.24 | Oracle Buy | Jefferies & Company Inc. | |
12.03.24 | Oracle Neutral | JP Morgan Chase & Co. | |
12.03.24 | Bayer Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
12.03.24 | Nike Outperform | RBC Capital Markets | |
11.03.24 | Bayer Kaufen | DZ BANK | |
11.03.24 | Nike Buy | UBS AG | |
07.03.24 | Nike Outperform | Bernstein Research | |
07.03.24 | Bayer Hold | Deutsche Bank AG | |
07.03.24 | Oracle Buy | UBS AG | |
07.03.24 | Bayer Market-Perform | Bernstein Research | |
07.03.24 | Apple Neutral | UBS AG | |
07.03.24 | Pfizer Neutral | JP Morgan Chase & Co. | |
07.03.24 | Intel Neutral | UBS AG | |
07.03.24 | Boeing Buy | UBS AG | |
06.03.24 | Bayer Equal Weight | Barclays Capital | |
06.03.24 | Bayer Neutral | JP Morgan Chase & Co. | |
05.03.24 | Bayer Hold | Jefferies & Company Inc. | |
05.03.24 | Bayer Outperform | Bernstein Research | |
05.03.24 | Bayer Neutral | UBS AG | |
05.03.24 | Bayer Hold | Deutsche Bank AG | |
05.03.24 | Bayer Neutral | JP Morgan Chase & Co. | |
05.03.24 | Bayer Hold | Jefferies & Company Inc. | |
04.03.24 | Boeing Overweight | JP Morgan Chase & Co. | |
01.03.24 | Pfizer Neutral | JP Morgan Chase & Co. | |
01.03.24 | Bayer Equal Weight | Barclays Capital | |
29.02.24 | JPMorgan Chase Buy | Jefferies & Company Inc. | |
28.02.24 | Apple Neutral | UBS AG | |
28.02.24 | Bayer Equal Weight | Barclays Capital | |
27.02.24 | Intel Market-Perform | Bernstein Research |